Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2021
Filed with the SEC on Sep 1, 2021 and accepted by EDGAR at Aug 31, 2021, 19:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-05-01 to 2021-07-31 | $1.59bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-11-01 to 2021-07-31 | $4.66bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-05-01 to 2021-07-31 | $734.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-11-01 to 2021-07-31 | $2.15bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2021-05-01 to 2021-07-31 | $113.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-11-01 to 2021-07-31 | $325.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-05-01 to 2021-07-31 | $403.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-11-01 to 2021-07-31 | $1.23bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-05-01 to 2021-07-31 | $336.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-11-01 to 2021-07-31 | $952.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-05-01 to 2021-07-31 | $21.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-11-01 to 2021-07-31 | $60.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-05-01 to 2021-07-31 | $63.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-11-01 to 2021-07-31 | $144.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-05-01 to 2021-07-31 | $264.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-11-01 to 2021-07-31 | $768.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-05-01 to 2021-07-31 | $0.86 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-11-01 to 2021-07-31 | $2.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-05-01 to 2021-07-31 | $0.87 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-11-01 to 2021-07-31 | $2.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-05-01 to 2021-07-31 | 306,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-11-01 to 2021-07-31 | 307,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-11-01 to 2021-07-31 | $1.04bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-11-01 to 2021-07-31 | $126.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2021-05-01 to 2021-07-31 | $59.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2020-11-01 to 2021-07-31 | $177.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2020-11-01 to 2021-07-31 | $652.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-07-31 | $1.43bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-07-31 | $3.63bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-07-31 | $10.49bn | us-gaap:Assets |
| Current liabilities | At period end2021-07-31 | $1.72bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-07-31 | $5.54bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-07-31 | $2.73bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2021-07-31 | $130.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-07-31 | $4.95bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-21-000015. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.